Your institution may have access to this item. Find your institution then sign in to continue.
Title
People.
Abstract
Career developments involving geneticists worldwide are discussed. Robert Schaub has been appointed as vice president of preclinical discovery at Archemix Corp. Bernhard R. M. Ehmer has been appointed as non-executive independent director of the supervisory board of Hybrigenics SA. Johan Harmenberg has been appointed as chief medical officer of Algeta.